i
Home
About
Aggregate Report
FAQs
Contact Us
Login
Researches
Back
Excel File
Save as PDF
A.T. Development Switzerland SARL
Results 1 - 1 of 1
5
10
15
20
25
30
50
100
All
Public Title
Status
Date Registered
A phase 1, single center, double-blind, randomized, placebo-controlled, ascending dose study to investigate the Safety, Tolerability and Pharmacokinetic profiles of single doses of NC-503 in healthy J . . .
Registry ID:
PHRR150909-001085
Completed
09 Sep 2015